This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The Bay Zoltan Foundation for Applied Research, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: Miklos Toth: Innovator in Desensitization Methods
Introduction
Miklos Toth is a notable inventor based in Pilisborosjeno, Hungary. He has made significant contributions to the field of medicine, particularly in the area of desensitization methods for hypersensitivity reactions. His innovative approach has the potential to improve patient outcomes in the treatment of allergic reactions.
Latest Patents
Miklos Toth holds a patent for "Particulate drug carriers as desensitizing agents." This invention provides methods for desensitization aimed at preventing or diminishing hypersensitivity reactions, including C activation-related pseudoallergy (CARPA) and other reactions to particulate medicines. The desensitization process involves pretreatment using a drug-free vehicle or carrier to alleviate or reduce the clinical symptoms associated with hypersensitivity.
Career Highlights
Throughout his career, Toth has worked with various research institutions, including the Bay Zoltan Foundation for Applied Research and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding and treatment of hypersensitivity reactions.
Collaborations
Miklos Toth has collaborated with notable colleagues such as Yechezkel Barenholz and Janos Szebeni. These partnerships have contributed to the development of innovative solutions in the field of medicine.
Conclusion
Miklos Toth's contributions to the field of desensitization methods highlight his role as an important inventor in medical research. His work continues to pave the way for advancements in the treatment of hypersensitivity reactions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile